GlassScriptPhysician profile
Brian H Saluck
NPI 1295796902
$29,407.31
in general payments reported to CMS, 2019-2025
50 companies · $1,982 in 2025
The $1,982 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,798 · 2020: $1,385 · 2021: $12K · 2022: $6,377 · 2023: $1,375 · 2024: $1,660 · 2025: $1,982.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,841 · Travel and Lodging: $176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,840.51 |
| Travel and Lodging | $176.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $15,602.26 | 2020-2023 | Nexletol |
| Medtronic, INC. | $2,388.19 | 2021-2025 | Micra, Evera Mri Xt Dr Surescan, Symplicity G3 |
| Penumbra, INC. | $1,598.61 | 2019-2025 | Indigo System, Penumbra System, Ruby Coil |
| Medtronic Vascular, INC. | $1,432.44 | 2019-2020 | |
| Abbott Laboratories | $1,356.39 | 2019-2024 | Diamondback Coronary, Amplatzer Piccolo |
| Pfizer INC. | $897.14 | 2019-2025 | |
| Boston Scientific Corporation | $686.94 | 2019-2025 | Watchman Flx, Cds Broad Portfolio Offering, Lux-Dx Insertable Cardiac Monitor |
| Amgen INC. | $607.80 | 2019-2025 | Repatha, Repatha |
| Cardiovascular Systems INC. | $569.48 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $491.89 | 2019-2024 | Brilinta, Andexxa |
| Janssen Pharmaceuticals, INC | $488.13 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $454.60 | 2019-2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $408.89 | 2019-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $327.58 | 2022-2025 | Optimizer, Optimizer |
| W. L. Gore & Associates, INC. | $303.59 | 2019 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Saluck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.